Literature DB >> 24966583

Production and pathogenicity of hepatitis C virus core gene products.

Hui-Chun Li1, Hsin-Chieh Ma1, Chee-Hing Yang1, Shih-Yen Lo1.   

Abstract

Hepatitis C virus (HCV) is a major cause of chronic liver diseases, including steatosis, cirrhosis and hepatocellular carcinoma, and its infection is also associated with insulin resistance and type 2 diabetes mellitus. HCV, belonging to the Flaviviridae family, is a small enveloped virus whose positive-stranded RNA genome encoding a polyprotein. The HCV core protein is cleaved first at residue 191 by the host signal peptidase and further cleaved by the host signal peptide peptidase at about residue 177 to generate the mature core protein (a.a. 1-177) and the cleaved peptide (a.a. 178-191). Core protein could induce insulin resistance, steatosis and even hepatocellular carcinoma through various mechanisms. The peptide (a.a. 178-191) may play a role in the immune response. The polymorphism of this peptide is associated with the cellular lipid drop accumulation, contributing to steatosis development. In addition to the conventional open reading frame (ORF), in the +1 frame, an ORF overlaps with the core protein-coding sequence and encodes the alternative reading frame proteins (ARFP or core+1). ARFP/core+1/F protein could enhance hepatocyte growth and may regulate iron metabolism. In this review, we briefly summarized the current knowledge regarding the production of different core gene products and their roles in viral pathogenesis.

Entities:  

Keywords:  Alternative reading frame/core+1 proteins; Core protein; Hepatitis C virus; Hepatocellular carcinoma; Insulin resistance; Interferon; Steatosis

Mesh:

Substances:

Year:  2014        PMID: 24966583      PMCID: PMC4064058          DOI: 10.3748/wjg.v20.i23.7104

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  197 in total

1.  Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis.

Authors:  N Zhu; A Khoshnan; R Schneider; M Matsumoto; G Dennert; C Ware; M M Lai
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

2.  Interaction of hepatitis C virus core protein with retinoid X receptor alpha modulates its transcriptional activity.

Authors:  Takeya Tsutsumi; Tetsuro Suzuki; Takashi Shimoike; Ryosuke Suzuki; Kyoji Moriya; Yoshizumi Shintani; Hajime Fujie; Yoshiharu Matsuura; Kazuhiko Koike; Tatsuo Miyamura
Journal:  Hepatology       Date:  2002-04       Impact factor: 17.425

3.  Modulation of the type I interferon pathways by culture-adaptive hepatitis C virus core mutants.

Authors:  Ju-Il Kang; Young-Chan Kwon; Byung-Yoon Ahn
Journal:  FEBS Lett       Date:  2012-04-09       Impact factor: 4.124

4.  Cross-talk between programmed death-1 and suppressor of cytokine signaling-1 in inhibition of IL-12 production by monocytes/macrophages in hepatitis C virus infection.

Authors:  Ying Zhang; Cheng J Ma; Lei Ni; Chun L Zhang; Xiao Y Wu; Uday Kumaraguru; Chuan F Li; Jonathan P Moorman; Zhi Q Yao
Journal:  J Immunol       Date:  2011-01-24       Impact factor: 5.422

5.  High levels of HCV core+1 antibodies in HCV patients with hepatocellular carcinoma.

Authors:  G Dalagiorgou; N Vassilaki; P Foka; A Boumlic; A Kakkanas; E Kochlios; S Khalili; E Aslanoglou; S Veletza; G Orfanoudakis; D Vassilopoulos; S J Hadziyannis; J Koskinas; P Mavromara
Journal:  J Gen Virol       Date:  2011-02-09       Impact factor: 3.891

6.  Role of the hepatitis C virus core+1 open reading frame and core cis-acting RNA elements in viral RNA translation and replication.

Authors:  Niki Vassilaki; Peter Friebe; Philipe Meuleman; Stephanie Kallis; Artur Kaul; Glaucia Paranhos-Baccalà; Geert Leroux-Roels; Penelope Mavromara; Ralf Bartenschlager
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

7.  Specific polymorphisms in hepatitis C virus genotype 3 core protein associated with intracellular lipid accumulation.

Authors:  Ravi Jhaveri; John McHutchison; Keyur Patel; Guan Qiang; Anna Mae Diehl
Journal:  J Infect Dis       Date:  2008-01-15       Impact factor: 5.226

8.  Unusual multiple recoding events leading to alternative forms of hepatitis C virus core protein from genotype 1b.

Authors:  Steeve Boulant; Michel Becchi; François Penin; Jean-Pierre Lavergne
Journal:  J Biol Chem       Date:  2003-09-02       Impact factor: 5.157

Review 9.  Hepatitis C virus core protein, lipid droplets and steatosis.

Authors:  P Roingeard; C Hourioux
Journal:  J Viral Hepat       Date:  2007-12-17       Impact factor: 3.728

10.  Structural determinants that target the hepatitis C virus core protein to lipid droplets.

Authors:  Steeve Boulant; Roland Montserret; R Graham Hope; Maxime Ratinier; Paul Targett-Adams; Jean-Pierre Lavergne; Francois Penin; John McLauchlan
Journal:  J Biol Chem       Date:  2006-05-16       Impact factor: 5.157

View more
  12 in total

1.  Inhibitory effect of miR-125b on hepatitis C virus core protein-induced TLR2/MyD88 signaling in THP-1 cells.

Authors:  Cheng Peng; Hua Wang; Wen-Jing Zhang; Sheng-Hua Jie; Qiao-Xia Tong; Meng-Ji Lu; Dong-Liang Yang
Journal:  World J Gastroenterol       Date:  2016-05-07       Impact factor: 5.742

Review 2.  Hepatitis C virus: Virology, diagnosis and treatment.

Authors:  Hui-Chun Li; Shih-Yen Lo
Journal:  World J Hepatol       Date:  2015-06-08

Review 3.  Polymorphisms in the hepatitis C virus core and its association with development of hepatocellular carcinoma.

Authors:  Virginia Sedeno-Monge; Veronica Vallejo-Ruiz; Francisca Sosa-Jurado; Gerardo Santos-Lopez
Journal:  J Biosci       Date:  2017-09       Impact factor: 1.826

4.  Designing a recombinant Bacmid construct of HCV core+1 in Baculovirus expression system.

Authors:  Fahimeh Safarnezhad Tameshkel; Pooneh Rahimi; Mohammad Reza Khataminejad
Journal:  Iran J Microbiol       Date:  2015-08

5.  The Prevalence of Hepatitis C Virus Core Amino Acid 70 Substitution and Genotypes of Polymorphisms Near the IFNL3 Gene in Iranian Patients With Chronic Hepatitis C.

Authors:  Danesh Kadjbaf; Maryam Keshvari; Seyed Moayed Alavian; Ali Pouryasin; Bita Behnava; Shima Salimi; Leila Mehrnoush; Pegah Karimi Elizee; Heidar Sharafi
Journal:  Hepat Mon       Date:  2016-05-03       Impact factor: 0.660

6.  Hepatitis C Virus Increases Free Fatty Acids Absorption and Promotes its Replication Via Down-Regulating GADD45α Expression.

Authors:  Wei Chen; Xiao-Ming Li; An-Ling Li; Gui Yang; Han-Ning Hu
Journal:  Med Sci Monit       Date:  2016-07-06

7.  Determination of candidate metabolite biomarkers associated with recurrence of HCV-related hepatocellular carcinoma.

Authors:  Zhicheng Liu; Pierre Nahon; Zaifang Li; Peiyuan Yin; Yanli Li; Roland Amathieu; Nathalie Ganne-Carrié; Marianne Ziol; Nicolas Sellier; Olivier Seror; Laurence Le Moyec; Philippe Savarin; Guowang Xu
Journal:  Oncotarget       Date:  2017-12-15

Review 8.  HCV Proteins Modulate the Host Cell miRNA Expression Contributing to Hepatitis C Pathogenesis and Hepatocellular Carcinoma Development.

Authors:  Devis Pascut; Minh Hoang; Nhu N Q Nguyen; Muhammad Yogi Pratama; Claudio Tiribelli
Journal:  Cancers (Basel)       Date:  2021-05-19       Impact factor: 6.639

9.  Comparative Immunogenicity in Rabbits of the Polypeptides Encoded by the 5' Terminus of Hepatitis C Virus RNA.

Authors:  Irina Sominskaya; Juris Jansons; Anastasija Dovbenko; Natalia Petrakova; Ilva Lieknina; Marija Mihailova; Oleg Latyshev; Olesja Eliseeva; Irina Stahovska; Inara Akopjana; Ivars Petrovskis; Maria Isaguliants
Journal:  J Immunol Res       Date:  2015-11-02       Impact factor: 4.818

Review 10.  Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections.

Authors:  Maria Lina Tornesello; Luigi Buonaguro; Francesco Izzo; Franco M Buonaguro
Journal:  Oncotarget       Date:  2016-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.